The April 2026 order from the Department of Justice did two things. First, it placed FDA-approved cannabis products and state-licensed medical cannabis in Schedule III, effective immediately. Second, it initiated an expedited DEA administrative hearing that began June 29, 2026, to consider whether cannabis as a whole — including adult-use products — should be moved to Schedule III.
Recreational cannabis, even where it’s legal under state law, remains in Schedule I for now. Synthetically derived THC and unlicensed activity also remain Schedule I. Businesses in adult-use-only markets are not seeing federal tax relief yet, but the regulatory framework is in motion in a way it has not been before.
The expedited hearing, now underway, will be key. Outcomes from administrative hearings of this kind are rarely instantaneous, but the timeline has compressed considerably. Planning that assumed a multi-year process should be revisited this quarter.
The 280E question: what changes and what doesn’t
The single largest financial implication of rescheduling is the removal of Section 280E tax treatment for businesses dealing in Schedule III products. Retailers with FDA-approved or state-licensed medical cannabis products are already eligible for ordinary business deduction treatment on those product lines. For adult-use product lines, 280E continues to apply for now.
The financial math, courtesy of Headset modeling cited in industry reporting, suggests 280E costs retailers between $400,000 and more than $800,000 in extra tax liability per store each year. Full removal frees up that much annually, per location.
Three ways to get prepared for the upcoming changes:
Audit your Cost of Goods Sold (COGS) allocation methodology. Businesses with rigorous COGS accounting captured more deductions even under 280E, and they'll be best positioned post-rescheduling.
Separate medical and adult-use product line accounting where applicable. The tax treatment is already diverging for businesses carrying both.
Run scenario models on 280E removal for the full business. This is what tells you where reinvested cash flow should go — debt paydown, growth capex, or working capital.
Infrastructure decisions to make now
A few infrastructure decisions can improve your position regardless of how rescheduling plays out:
Data quality and product catalog hygiene. Federally legal Schedule III products will face FDA-style labeling and product information requirements that are stricter than most state regimes today. Retailers with verified product data through the Jane Catalog — cannabinoid profiles, dosage transparency, lab-verified terpene data, accurate imagery — are already operating closer to that standard. On the flip side, retailers relying on supplier-submitted data of variable quality will have a longer remediation list ahead of them.
Ecommerce flexibility. Federal banking and payment changes that follow rescheduling will likely arrive in waves rather than all at once. An ecommerce stack that can swap in new payment methods, comply with new reporting requirements, and adapt to interstate commerce rules without a full replatform is a hedge against regulatory turbulence. The hidden cost of a closed ecommerce ecosystem covers the broader case for flexibility — rescheduling is one of several reasons it matters in 2026.
Compliance documentation. Move every state-specific compliance process into auditable digital workflows now. The transition period after rescheduling will involve dual-track requirements (state plus federal) for at least a year. Businesses with paper-based or fragmented compliance records will struggle to demonstrate adherence to both.
Talking with banking and payment partners
The conversation cannabis retailers couldn’t get warm responses to two years ago has changed. Banking and payment providers are now actively planning for what their cannabis offerings look like in a Schedule III world.
Three questions worth raising with your current payment partners:
What is your roadmap for offering standard commercial banking products (e.g. lines of credit, merchant services, lower-fee ACH) to cannabis businesses if and when rescheduling moves forward?
How will pricing change on existing services that are currently priced to account for cannabis risk?
What documentation will you require from retailers to qualify for those products?
Initiating these conversations in mid-2026 gives your business a head start before the demand spike that follows any regulatory movement in cannabis. The ones that wait will be in line behind everyone else asking the same questions.
Rescheduling is moving more concretely than at any previous point, with FDA-approved and state-licensed medical cannabis already on Schedule III and the broader question under expedited DEA hearing.
280E removal is worth $400,000 to $800,000+ per store annually — six figures for a single location, likely seven for a multi-store operator — and the modeling and COGS-allocation work to capture it should happen sooner rather than later.
Data quality and ecommerce flexibility are no-regret investments that pay off whether rescheduling completes quickly, slowly, or partially.
Banking and payment conversations have shifted — partners are now actively planning for a Schedule III world, and businesses that engage early will move first when products come online.
Peter Prial
General Counsel
Peter is our resident expert on cannabis law and regulation, with deep experience navigating the industry's shifting legal landscape.
Rachel Melnick Schaaf
VP Partner Success & Tech Support
Rachel is your dedicated expert for Jane POS and Ecommerce with over 5 years in cannabis. She’s here to answer any questions and support you at every step to ensure your success.
Explore more
Ecommerce Premium
Grow online with a fully automated, branded storefront, smarter menus powered by AI, and built-in revenue drivers like MyHigh & Jane Gold.
Media
Drive growth with targeted advertising and premium menu placements that influence high-intent shoppers from discovery to checkout.
MyHigh
Create personalized shopping journeys with AI that learns each customer’s preferences and guides them to the right products faster.